Jewish Women Declare Victory on Supreme Court BRCA Gene Mutation Case

Barrier To Testing for 'Jewish' Cancer Gene Is Removed

courtesy of Lisa schlager

By Anne Cohen

Published June 13, 2013.
  • Print
  • Share Share
  • Single Page

Joanna Rudnick, a breast cancer survivor and BRCA-1 gene carrier, turned 39 today — and got one heck of a birthday present.

The Supreme Court unanimously ruled that human genes cannot be patented, although it reiterated that synthetic or altered genes may be subject to patent law. In other words, human DNA cannot be patented without being altered in some way.

Advocates called the decision a major victory.

“My life has exploded over the Myriad ruling,” she gushed on the phone. “This is an incredible birthday present. It is a victory. The barrier for women to get tested for BRCA 1 and 2 will now be gone. “

Rudnick is one thousands of Jewish women to be affected by this ruling: Ashkenazi Jews are much more likely to carry the BRCA mutation than the general population.

The court case pitted the American Civil Liberties Union (ACLU) against Myriad Genetics Inc., the biopharmaceutical company that owned the patents on the BRCA-1 and BRCA-2 genes, whose mutations are linked to increased hereditary risk for breast and ovarian cancer.

Writing for the court, Justice Clarence Thomas explained: “A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated,” he said. “It is undisputed that Myriad did not create or alter any of the genetic information encoded in the BRCA-1 and BRCA-2 genes.” “Groundbreaking, innovative or even brilliant discovery does not by itself satisfy the criteria” for patent eligibility, he added.

For Arthur Caplan, head of the Division of Bioethics at New York University’s Langone Medical Center, the Supreme Court made the right decision.

“Immediately [the decision] means that testing should become more available for breast cancer and ovarian cancer using the Myriad test at a lower price,” explained. “Longer term this decision throws into a tizzy a huge number of existing patents,” Caplan said. “The other fallout [is still] uncertain. It’s clear that you can take [out] patents, you just have to take them on products, not on genes.

Sue Friedman, founder and executive director of FORCE: Facing Our Risk Of Cancer Empowered, agreed. As a 17-year cancer survivor and a BRCA-2 carrier, Friedman was elated.

“Personally for me, for my family, for my relatives, this is significant, but also for people who may have a mutation and have not been able to get access to that information. They are part of that extended family that we’ve built through FORCE,” she said.


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • "I’ve never bought illegal drugs, but I imagine a small-time drug deal to feel a bit like buying hummus underground in Brooklyn."
  • We try to show things that get less exposed to the public here. We don’t look to document things that are nice or that people would like. We don’t try to show this place as a beautiful place.”
  • A new Gallup poll shows that only 25% of Americans under 35 support the war in #Gaza. Does this statistic worry you?
  • “You will stomp us into the dirt,” is how her mother responded to Anya Ulinich’s new tragicomic graphic novel. Paul Berger has a more open view of ‘Lena Finkle’s Magic Barrel." What do you think?
  • PHOTOS: Hundreds of protesters marched through lower Manhattan yesterday demanding an end to American support for Israel’s operation in #Gaza.
  • Does #Hamas have to lose for there to be peace? Read the latest analysis by J.J. Goldberg.
  • This is what the rockets over Israel and Gaza look like from space:
  • "Israel should not let captives languish or corpses rot. It should do everything in its power to recover people and bodies. Jewish law places a premium on pidyon shvuyim, “the redemption of captives,” and proper burial. But not when the price will lead to more death and more kidnappings." Do you agree?
  • Slate.com's Allison Benedikt wrote that Taglit-Birthright Israel is partly to blame for the death of American IDF volunteer Max Steinberg. This is why she's wrong:
  • Israeli soldiers want you to buy them socks. And snacks. And backpacks. And underwear. And pizza. So claim dozens of fundraising campaigns launched by American Jewish and Israeli charities since the start of the current wave of crisis and conflict in Israel and Gaza.
  • The sign reads: “Dogs are allowed in this establishment but Zionists are not under any circumstances.”
  • Is Twitter Israel's new worst enemy?
  • More than 50 former Israeli soldiers have refused to serve in the current ground operation in #Gaza.
  • "My wife and I are both half-Jewish. Both of us very much felt and feel American first and Jewish second. We are currently debating whether we should send our daughter to a Jewish pre-K and kindergarten program or to a public one. Pros? Give her a Jewish community and identity that she could build on throughout her life. Cons? Costs a lot of money; She will enter school with the idea that being Jewish makes her different somehow instead of something that you do after or in addition to regular school. Maybe a Shabbat sing-along would be enough?"
  • Undeterred by the conflict, 24 Jews participated in the first ever Jewish National Fund— JDate singles trip to Israel. Translation: Jews age 30 to 45 travelled to Israel to get it on in the sun, with a side of hummus.
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.